127 related articles for article (PubMed ID: 1832081)
1. The inhibitory effect of 4-hydroxyphenyl retinamide (4-HPR) on metastasis of prostate adenocarcinoma-III cells in Lobund-Wistar rats.
Pollard M; Luckert PH
Cancer Lett; 1991 Aug; 59(2):159-63. PubMed ID: 1832081
[TBL] [Abstract][Full Text] [Related]
2. Prevention of primary prostate cancer in Lobund-Wistar rats by N-(4-hydroxyphenyl)retinamide.
Pollard M; Luckert PH; Sporn MB
Cancer Res; 1991 Jul; 51(13):3610-1. PubMed ID: 1829024
[TBL] [Abstract][Full Text] [Related]
3. Thalidomide promotes metastasis of prostate adenocarcinoma cells (PA-III) in L-W rats.
Pollard M
Cancer Lett; 1996 Mar; 101(1):21-4. PubMed ID: 8625277
[TBL] [Abstract][Full Text] [Related]
4. Suppression of rat mammary cancer development by N-(4-hydroxyphenyl)retinamide (4-HPR) following surgical removal of first palpable tumor.
Moon RC; Pritchard JF; Mehta RG; Nomides CT; Thomas CF; Dinger NM
Carcinogenesis; 1989 Sep; 10(9):1645-9. PubMed ID: 2527636
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of fenretinide metabolites N-[4-methoxyphenyl]retinamide (MPR) and 4-oxo-N-(4-hydroxyphenyl)retinamide (3-keto-HPR) on fenretinide molecular targets β-carotene oxygenase 1, stearoyl-CoA desaturase 1 and dihydroceramide Δ4-desaturase 1.
Poliakov E; Samuel W; Duncan T; Gutierrez DB; Mata NL; Redmond TM
PLoS One; 2017; 12(4):e0176487. PubMed ID: 28448568
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapeutic evaluation of glucarate and N-(4-hydroxyphenyl)retinamide alone and in combination in the rat mammary tumor model.
Abou-Issa H; Webb TE; Minton JP; Moeschberger M
J Natl Cancer Inst; 1989 Dec; 81(23):1820-3. PubMed ID: 2531231
[TBL] [Abstract][Full Text] [Related]
7. The anti-metastatic effect of intravenously-inoculated BCG on prostate tumor cells.
Pollard M; Luckert PH
Anticancer Res; 1993; 13(3):705-8. PubMed ID: 8317900
[TBL] [Abstract][Full Text] [Related]
8. Enhanced inhibition of mammary carcinogenesis by combined treatment with N-(4-hydroxyphenyl)retinamide and ovariectomy.
McCormick DL; Mehta RG; Thompson CA; Dinger N; Caldwell JA; Moon RC
Cancer Res; 1982 Feb; 42(2):508-12. PubMed ID: 6459843
[TBL] [Abstract][Full Text] [Related]
9. Effect of N-(4-hydroxyphenyl) retinamide on food intake, growth, and mammary gland development in rats.
Radcliffe JD; Moon RC
Proc Soc Exp Biol Med; 1983 Nov; 174(2):270-5. PubMed ID: 6227008
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of mammary tumorigenesis in nulliparous C3H mice by chronic feeding of the synthetic retinoid, N-(4-hydroxyphenyl)-retinamide.
Welsch CW; DeHoog JV; Moon RC
Carcinogenesis; 1983 Sep; 4(9):1185-7. PubMed ID: 6224605
[TBL] [Abstract][Full Text] [Related]
11. Putative metabolites derived from dietary combinations of calcium glucarate and N-(4-hydroxyphenyl)retinamide act synergistically to inhibit the induction of rat mammary tumors by 7,12-dimethylbenz[a]anthracene.
Abou-Issa HM; Duruibe VA; Minton JP; Larroya S; Dwivedi C; Webb TE
Proc Natl Acad Sci U S A; 1988 Jun; 85(12):4181-4. PubMed ID: 2967969
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of metastasis of prostate adenocarcinoma cells by immune-suppressive cyclosporine A.
Pollard M
Cancer Lett; 1997 Jan; 111(1-2):221-4. PubMed ID: 9022150
[TBL] [Abstract][Full Text] [Related]
13. Biotransformation and biological activity of N-(4-hydroxyphenyl)retinamide derivatives in rodents.
Swanson BN; Newton DL; Roller PP; Sporn MB
J Pharmacol Exp Ther; 1981 Dec; 219(3):632-7. PubMed ID: 6170750
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of rat mammary gland chemical carcinogenesis by dietary dehydroepiandrosterone or a fluorinated analogue of dehydroepiandrosterone.
Ratko TA; Detrisac CJ; Mehta RG; Kelloff GJ; Moon RC
Cancer Res; 1991 Jan; 51(2):481-6. PubMed ID: 1824682
[TBL] [Abstract][Full Text] [Related]
15. Interference with in vivo growth and metastasis of prostate adenocarcinoma (PA-III) by ICRF-159.
Pollard M; Burleson GR; Luckert PH
Prostate; 1981; 2(1):1-9. PubMed ID: 7279810
[TBL] [Abstract][Full Text] [Related]
16. Effects of pretreatment with the retinoid N-(4-hydroxyphenyl)-all-trans-retinamide and phenobarbital on the disposition and metabolism of N-(4-hydroxyphenyl)-all-trans-retinamide in mice.
Hultin TA; McCormick DL; May CM; Moon RC
Drug Metab Dispos; 1988; 16(6):783-8. PubMed ID: 2907453
[TBL] [Abstract][Full Text] [Related]
17. Secretion of vitamin A and retinol-binding protein into plasma is depressed in rats by N-(4-hydroxyphenyl)retinamide (fenretinide).
Smith JE; Lawless DC; Green MH; Moon RC
J Nutr; 1992 Oct; 122(10):1999-2009. PubMed ID: 1388202
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic effect of N-(4-hydroxyphenyl)retinamide on N-methyl-N-nitrosourea-induced rat mammary cancer.
Dowlatshahi K; Mehta RG; Thomas CF; Dinger NM; Moon RC
Cancer Lett; 1989 Oct; 47(3):187-92. PubMed ID: 2534548
[TBL] [Abstract][Full Text] [Related]
19. Small intestinal submucosa does not promote PAIII tumor growth in Lobund-Wistar rats.
Hodde JP; Suckow MA; Wolter WR; Hiles MC
J Surg Res; 2004 Aug; 120(2):189-94. PubMed ID: 15234212
[TBL] [Abstract][Full Text] [Related]
20. Effects of dichloromethylene diphosphonate on the osteolytic and osteoplastic effects of rat prostate adenocarcinoma cells.
Pollard M; Luckert PH
J Natl Cancer Inst; 1985 Nov; 75(5):949-54. PubMed ID: 2932588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
